OMRX — Orthometrix Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Orthometrix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2003 December 31st | 2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB | 10KSB | 10KSB | 10KSB |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.57 | 1.18 | 1.51 | 2.36 | 2.41 |
| Cost of Revenue | |||||
| Gross Profit | 1.06 | 0.651 | 0.901 | 1.5 | 1.07 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 2.87 | 2.84 | 3.85 | 4 | 2.83 |
| Operating Profit | -1.3 | -1.66 | -2.34 | -1.64 | -0.415 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.35 | -1.95 | -2.39 | -1.98 | -1.07 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.35 | -1.95 | -2.39 | -1.98 | -1.07 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -1.35 | -1.95 | -2.39 | -1.98 | -1.07 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -1.35 | -1.95 | -2.39 | -1.98 | -1.07 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.046 | -0.062 | -0.057 | -0.044 | -0.024 |
| Dividends per Share |